Mimi C Tan
Overview
Explore the profile of Mimi C Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel A, Gandle C, Baerman E, Lill I, Pecha R, Nguyen Wenker T, et al.
J Clin Gastroenterol
. 2025 Jan;
PMID: 39761160
Objective: Even though the prevalence of malignancy within gastric ulcers is low, surveillance endoscopy is routinely performed after gastric ulcer diagnosis resulting in unnecessary costs and risks. Endoscopic appearance may...
2.
Liu K, George R, Shin C, Xiong J, Jamali T, Liu Y, et al.
Dig Dis Sci
. 2024 Nov;
70(1):350-359.
PMID: 39581897
Background/aims: Fecal occult blood test (FOBT) and fecal immunohistochemical test (FIT) are used for colorectal cancer (CRC) screening. However, when no adenomas are found following a positive FOBT/FIT, the future...
3.
Tan M, Li Z, Patel K, Zhang F, Yu X, Wang X, et al.
Gastroenterology
. 2024 Oct;
168(3):496-507.e3.
PMID: 39477026
Background & Aims: Lugol's chromoendoscopy (LCE)-based detection of esophageal squamous cell neoplasia (ESCN) is limited by low specificity. High-resolution microendoscopy (HRME) was shown to improve specificity and reduce unnecessary biopsies...
4.
da Costa Jr. W, Tan M, Camp E, Thrift A
J Surg Oncol
. 2024 May;
129(8):1542-1553.
PMID: 38752435
Background: Disparities in gastric cancer (GC) outcomes show a higher disease burden among minorities. We aimed to evaluate the associations between sociodemographic and system-level factors and guideline-concordant treatment among GC...
5.
Moss S, Shah S, Tan M, El-Serag H
Gastroenterology
. 2023 Oct;
166(2):267-283.
PMID: 37806461
Helicobacter pylori is the most common chronic bacterial infection worldwide and the most significant risk factor for gastric cancer, which remains a leading cause of cancer-related death globally. H pylori...
6.
Price A, Graham D, Tan M
Curr Opin Gastroenterol
. 2023 Sep;
39(6):482-489.
PMID: 37678189
Purpose Of Review: The recognition that Helicobacter pylori should be considered and treated as an infectious disease has yet to fundamentally change diagnostic and treatment practices and has resulted in...
7.
Jacob J, Millien V, Berger S, Hernaez R, Ketwaroo G, Flores A, et al.
J Clin Gastroenterol
. 2023 Jul;
58(5):432-439.
PMID: 37436841
Background: Clinical guidelines reserve endoscopic surveillance after a gastric intestinal metaplasia (GIM) diagnosis for high-risk patients. However, it is unclear how closely guidelines are followed in clinical practice. We examined...
8.
Tan M, Sen A, Kligman E, Othman M, Liu Y, El-Serag H, et al.
Gastrointest Endosc
. 2023 May;
98(4):569-576.e1.
PMID: 37207845
Background And Aims: Surveillance of gastric intestinal metaplasia (GIM) may lead to early gastric cancer detection. Our purpose was to externally validate a predictive model for endoscopic GIM previously developed...
9.
Tan M, Morgan D
Clin Gastroenterol Hepatol
. 2023 May;
21(13):3234-3235.
PMID: 37178896
No abstract available.
10.
Wenker T, Peng F, Emelogu I, Mallepally N, Kanwal F, El-Serag H, et al.
Clin Gastroenterol Hepatol
. 2022 Oct;
21(7):1771-1780.
PMID: 36270616
Background: The Houston Consensus Conference and American College of Gastroenterology (ACG) have recommended Helicobacter pylori screening in United States populations with specific risk factors. However, the performance of these guidelines...